\-\ Texto\\:\\ \ \(0\)\
\-\ thin\\,\\ elderly\\ female\\ with\\ marked\\ kyphosis\\.\ \(0\)\
\-\ labs\\ are\\ significant\\ for\\ a\\ serum\\ pth\\ of\\ 127\\ \\(normal\\ range\\,\\ 15\\-65\\)\\,\\ calcium\\ 11\\.8\\,\\ and\\ phosphorus\\ 2\\.4\\.\ \(0\)\
\-\ surgery\\ for\\ removal\\ of\\ the\\ adenoma\\.\ \(0\)\
\-\ tc\\-99m\\ sestamibi\\ scan\\ \\(21\\.8\\ mci\\ iv\\)\\ at\\ 20\\-minutes\\ and\\ 2\\-hours\\ post\\ injection\\.\\ \\ 20\\-minute\\ scan\\ demonstrates\\ diffuse\\ uptake\\ within\\ the\\ thyroid\\ gland\\ with\\ a\\ focus\\ of\\ increased\\ uptake\\ in\\ the\\ region\\ of\\ the\\ left\\ lower\\ pole\\,\\ which\\ persists\\ on\\ the\\ 2\\-hour\\ scan\\.\ \(0\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ thyroid\\ adenoma\ \(56\)\
\-\ parathyroid\\ hyperplasia\ \(5\)\
\-\ 82\\ year\\ old\\ female\\ with\\ primary\\ hyperparathyroidism\\,\\ right\\ hip\\ fracture\\,\\ and\\ multiple\\ vertebral\\ body\\ compression\\ fractures\\.\ \(1\)\
\-\ parathyroid\\ imaging\\ is\\ done\\ at\\ wramc\\ using\\ tc\\-99m\\ sestamibi\\ with\\ a\\ dosage\\ of\\ 20\\ mci\\ iv\\.\\ \\ scanning\\ is\\ performed\\ 20\\-minutes\\ and\\ 2\\-hours\\ post\\ injection\\.\\ \\ the\\ imaging\\ is\\ based\\ on\\ the\\ differential\\ uptake\\ and\\ washout\\ of\\ the\\ radiotracer\\ from\\ the\\ thyroid\\ and\\ parathyroid\\.\\ \\ a\\ parathyroid\\ adenoma\\ should\\ have\\ avid\\ uptake\\ of\\ the\\ radiotracer\\,\\ and\\ at\\ 2\\-hours\\ increased\\ uptake\\ should\\ be\\ seen\\ in\\ the\\ adenoma\\ while\\ the\\ radiotracer\\ is\\ expected\\ to\\ have\\ washed\\ out\\ from\\ the\\ thyroid\\ gland\\.\\ \\ \\ false\\ positives\\ may\\ result\\ from\\ increased\\ uptake\\ secondary\\ to\\ a\\ thyroid\\ adenoma\\.\\ \\ if\\ no\\ increased\\ focus\\ of\\ uptake\\ is\\ seen\\ on\\ the\\ planar\\ images\\,\\ additional\\ tomographic\\ \\(spect\\)\\ images\\ can\\ be\\ obtained\\.\ \(0\)\
\-\ it\\ is\\ important\\ to\\ note\\ that\\ the\\ parathyroid\\ scan\\ is\\ not\\ used\\ to\\ diagnose\\ hyperparathyroidism\\.\\ \\ this\\ is\\ a\\ diagnosis\\ made\\ based\\ on\\ laboratory\\ and\\ clinical\\ findings\\.\\ the\\ parathyroid\\ scan\\ is\\ used\\ to\\ identify\\ and\\ localize\\ parathyroid\\ adenomas\\ in\\ a\\ patient\\ for\\ which\\ surgery\\ is\\ being\\ planned\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parathyroid\\:\\ 0\\.5286372867916816\ \(0\)\
\-\ adenoma\\:\\ 0\\.2986888842376457\ \(0\)\
\-\ uptake\\:\\ 0\\.28808278452153707\ \(0\)\
\-\ thyroid\\:\\ 0\\.21030642668525637\ \(0\)\
\-\ the\\:\\ 0\\.17087078323896696\ \(0\)\
\-\ scan\\:\\ 0\\.15876774653337583\ \(0\)\
\-\ is\\:\\ 0\\.14657151420660272\ \(0\)\
\-\ radiotracer\\:\\ 0\\.1401573217168828\ \(0\)\
\-\ 20\\:\\ 0\\.13811430908037603\ \(0\)\
\-\ sestamibi\\:\\ 0\\.13466915859942627\ \(0\)\
\-\ mci\\:\\ 0\\.1223446831478386\ \(0\)\
\-\ increased\\:\\ 0\\.11576693662059742\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.10196231981579437\ \(0\)\
\-\ and\\:\\ 0\\.09953555524128821\ \(0\)\
\-\ injection\\:\\ 0\\.09314269638074764\ \(0\)\
\-\ focus\\:\\ 0\\.09067366453409191\ \(0\)\
\-\ gland\\:\\ 0\\.08695487222087558\ \(0\)\
\-\ of\\:\\ 0\\.08379093658153086\ \(0\)\
\-\ used\\:\\ 0\\.08013578167369799\ \(0\)\
\-\ washed\\:\\ 0\\.07908863495799794\ \(0\)\
\-\ based\\:\\ 0\\.07753866051505477\ \(0\)\
\-\ iv\\:\\ 0\\.0764838202143766\ \(0\)\
\-\ positives\\:\\ 0\\.07383803665323796\ \(0\)\
\-\ dosage\\:\\ 0\\.07258517760447311\ \(0\)\
\-\ should\\:\\ 0\\.06984519346287982\ \(0\)\
\-\ kyphosis\\:\\ 0\\.06959728366580457\ \(0\)\
\-\ 127\\:\\ 0\\.06878089892762185\ \(0\)\
\-\ phosphorus\\:\\ 0\\.06878089892762185\ \(0\)\
\-\ wramc\\:\\ 0\\.06878089892762185\ \(0\)\
\-\ to\\:\\ 0\\.06690100710115136\ \(0\)\
\-\ persists\\:\\ 0\\.06497662025077057\ \(0\)\
\-\ on\\:\\ 0\\.06465731596784145\ \(0\)\
\-\ localize\\:\\ 0\\.06446933424050248\ \(0\)\
\-\ washout\\:\\ 0\\.06398807461494684\ \(0\)\
\-\ tomographic\\:\\ 0\\.06398807461494684\ \(0\)\
\-\ from\\:\\ 0\\.06376908595659164\ \(0\)\
\-\ pth\\:\\ 0\\.06353030062286186\ \(0\)\
\-\ adenomas\\:\\ 0\\.062277441574097016\ \(0\)\
\-\ spect\\:\\ 0\\.0611723415739193\ \(0\)\
\-\ at\\:\\ 0\\.06064693409913531\ \(0\)\
\-\ avid\\:\\ 0\\.06050187743900133\ \(0\)\
\-\ planar\\:\\ 0\\.06018379593809556\ \(0\)\
\-\ diagnose\\:\\ 0\\.059876145239456516\ \(0\)\
\-\ post\\:\\ 0\\.05824521467132379\ \(0\)\
\-\ scanning\\:\\ 0\\.058216091866503346\ \(0\)\
\-\ false\\:\\ 0\\.05772216173845147\ \(0\)\
\-\ surgery\\:\\ 0\\.05755054985588469\ \(0\)\
\-\ identify\\:\\ 0\\.057026843269337026\ \(0\)\
\-\ elderly\\:\\ 0\\.05637951726124428\ \(0\)\
\-\ imaging\\:\\ 0\\.05625443130760943\ \(0\)\
\-\ planned\\:\\ 0\\.054844263264413294\ \(0\)\
\-\ 82\\:\\ 0\\.05449672332275347\ \(0\)\
\-\ have\\:\\ 0\\.05347357642862507\ \(0\)\
\-\ female\\:\\ 0\\.05165292041294296\ \(0\)\
\-\ seen\\:\\ 0\\.0503947198957209\ \(0\)\
\-\ images\\:\\ 0\\.049514260763611866\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.048794155236222\ \(0\)\
\-\ which\\:\\ 0\\.04867326813591819\ \(0\)\
\-\ for\\:\\ 0\\.04866561871613489\ \(0\)\
\-\ calcium\\:\\ 0\\.04834080591088846\ \(0\)\
\-\ expected\\:\\ 0\\.048252706618792204\ \(0\)\
\-\ serum\\:\\ 0\\.04799326596922864\ \(0\)\
\-\ pole\\:\\ 0\\.0466449368473928\ \(0\)\
\-\ important\\:\\ 0\\.045336832267045955\ \(0\)\
\-\ using\\:\\ 0\\.04401992856228737\ \(0\)\
\-\ be\\:\\ 0\\.04342284362092287\ \(0\)\
\-\ done\\:\\ 0\\.042573608934378664\ \(0\)\
\-\ with\\:\\ 0\\.04192050082308602\ \(0\)\
\-\ thin\\:\\ 0\\.04166196951334482\ \(0\)\
\-\ range\\:\\ 0\\.041532553590194685\ \(0\)\
\-\ additional\\:\\ 0\\.04148980861570381\ \(0\)\
\-\ made\\:\\ 0\\.04127895691819319\ \(0\)\
\-\ hip\\:\\ 0\\.041113622143568854\ \(0\)\
\-\ removal\\:\\ 0\\.04091096835455055\ \(0\)\
\-\ vertebral\\:\\ 0\\.04087095760874653\ \(0\)\
\-\ marked\\:\\ 0\\.040479963298377206\ \(0\)\
\-\ note\\:\\ 0\\.040290411282369445\ \(0\)\
\-\ result\\:\\ 0\\.040067890836848995\ \(0\)\
\-\ in\\:\\ 0\\.03994303228965374\ \(0\)\
\-\ fractures\\:\\ 0\\.03956832387734336\ \(0\)\
\-\ compression\\:\\ 0\\.03919365499610092\ \(0\)\
\-\ laboratory\\:\\ 0\\.038865561928526686\ \(0\)\
\-\ obtained\\:\\ 0\\.03785769083649354\ \(0\)\
\-\ being\\:\\ 0\\.03729569618333317\ \(0\)\
\-\ labs\\:\\ 0\\.037079996898180444\ \(0\)\
\-\ body\\:\\ 0\\.03522389573920845\ \(0\)\
\-\ out\\:\\ 0\\.035180256099268094\ \(0\)\
\-\ differential\\:\\ 0\\.034775499564668355\ \(0\)\
\-\ while\\:\\ 0\\.034589701301730294\ \(0\)\
\-\ clinical\\:\\ 0\\.03391923716681234\ \(0\)\
\-\ diffuse\\:\\ 0\\.03356443348332416\ \(0\)\
\-\ primary\\:\\ 0\\.03290978025449779\ \(0\)\
\-\ region\\:\\ 0\\.032013978428245306\ \(0\)\
\-\ secondary\\:\\ 0\\.031723380452152984\ \(0\)\
\-\ performed\\:\\ 0\\.031663332210883355\ \(0\)\
\-\ if\\:\\ 0\\.031097162452226323\ \(0\)\
\-\ significant\\:\\ 0\\.03090197698923301\ \(0\)\
\-\ fracture\\:\\ 0\\.030417958208923603\ \(0\)\
\-\ can\\:\\ 0\\.02808624394820547\ \(0\)\
\-\ diagnosis\\:\\ 0\\.027745024320474477\ \(0\)\
\-\ it\\:\\ 0\\.027396767637232807\ \(0\)\
\-\ lower\\:\\ 0\\.02734940506481344\ \(0\)\
\-\ may\\:\\ 0\\.026933568663399368\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02688848205250337\ \(0\)\
\-\ findings\\:\\ 0\\.0264148718816761\ \(0\)\
\-\ multiple\\:\\ 0\\.026178396575142076\ \(0\)\
\-\ within\\:\\ 0\\.02465022638813989\ \(0\)\
\-\ that\\:\\ 0\\.02322620504498341\ \(0\)\
\-\ normal\\:\\ 0\\.02185235778622533\ \(0\)\
\-\ not\\:\\ 0\\.0211289069704725\ \(0\)\
\-\ are\\:\\ 0\\.020308871215054813\ \(0\)\
\-\ this\\:\\ 0\\.01839085716343079\ \(0\)\
\-\ left\\:\\ 0\\.018257257557712507\ \(0\)\
\-\ right\\:\\ 0\\.017744500973486885\ \(0\)\
\-\ patient\\:\\ 0\\.017407768059120293\ \(0\)\
\-\ no\\:\\ 0\\.01740449375942817\ \(0\)\
\-\ year\\:\\ 0\\.016494188174411353\ \(0\)\
\-\ old\\:\\ 0\\.015840130252364314\ \(0\)\
